Department of Biostatistics

January 14, 2022

Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.

By Tom Wilemon
From left, Dandan Liu, PhD, Alan Storrow, MD, and Sunil Kripalani, MD, MSc, are testing the real-world implementation of a risk stratification tool to avoid unnecessary hospital admissions of patients diagnosed with acute heart failure in the emergency department.
November 11, 2021

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

By Bill Snyder
November 11, 2021

VUMC tests drugs for COVID outpatient treatment

By Paul Govern
September 9, 2021

Raman, Balucan receive health equity research grants

Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.

By Craig Boerner
July 27, 2021

Prediction models for breast cancer

Vanderbilt researchers developed new prognostic models for breast cancer outcomes and found that adding postdiagnostic weight change as a factor improves the prediction.

By Leigh MacMillan
April 15, 2021

Method proposed to correct misinterpretations of long-term survival rates for immunotherapies

Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.

By Tom Wilemon
April 1, 2021

Study outlines VUMC’s strategy for a learning health care system

New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.
By Paul Govern
December 15, 2020

A deeper look at out-of-home care

Geographically targeted efforts to prevent children being placed in out-of-home care might be possible, Vanderbilt researchers report.
By Bill Snyder
October 30, 2020

VUMC mourns loss of Biostatistics pioneer Federspiel

Charles Foster (Chuck) Federspiel, PhD, a beloved member of the Vanderbilt University faculty for 61 years and founding director of the Division of Biostatistics, died on Oct. 19. He was 91.
By Bill Snyder
September 24, 2020

Follow-up calls don’t impact readmission, mortality rates: study

Following up with adult general medicine patients by phone within the week after their hospital discharge as a stand-alone intervention has no impact on readmissions, mortality or patient satisfaction, according to a new study by Vanderbilt University Medical Center researchers.
By Kelsey Herbers
August 31, 2020

Vaccine narrows racial disparities in pneumococcal disease

In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease.
By Paul Govern
May 28, 2020

Multinational consortium reports COVID-19 impact on cancer patients

People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from a multinational perspective. The data on more than 900 patients, published May 28 in The Lancet and simultaneously presented at ASCO20 Virtual, also revealed cancer-specific factors associated with increased mortality.
By Tom Wilemon
April 9, 2020

Research team awarded $9 million to study extracellular RNA in colorectal cancer

The NCI program project grant is supporting multiple projects that aim to define fundamental biological principles about extracellular RNA signaling and the development and aggressiveness of colorectal cancer, the second leading cause of cancer death in the United States.
By Leigh MacMillan
1 2 3 4 5 6